AAAAAA

   
Results: 1-13 |
Results: 13

Authors: MAURITZ R BEKKENK MW ROTS MG PIETERS R MINI E VANZANTWIJK CH VEERMAN AJP PETERS GJ JANSEN G
Citation: R. Mauritz et al., EX-VIVO ACTIVITY OF METHOTREXATE VERSUS NOVEL ANTIFOLATE INHIBITORS OF DIHYDROFOLATE-REDUCTASE AND THYMIDYLATE SYNTHASE AGAINST CHILDHOOD LEUKEMIA-CELLS, Clinical cancer research, 4(10), 1998, pp. 2399-2410

Authors: ROTS MG NOORDHUIS P WILLEY JC VANZANTWIJK CH DEMUTH JP VEERMAN AJP PIETERS R PETERS GJ JANSEN G
Citation: Mg. Rots et al., EXPRESSION OF MESSENGER-RNA ENCODING FOR THE REDUCED FOLATE CARRIER AND FOLATE METABOLIZING ENZYMES IN CHILDHOOD LEUKEMIA-CELLS AS MEASUREDWITH A COMPETITIVE TEMPLATE RT-PCR METHOD, Annals of oncology, 9, 1998, pp. 620-620

Authors: HAARMAN EG KASPERS GJL PIETERS R BROEKEMA GJ VANZANTWIJK CH HAHLEN K VEERMAN AP
Citation: Eg. Haarman et al., BCL-2-EXPRESSION, SPONTANEOUS AND DRUG-INDUCED APOPTOSIS IN CHILDHOODLEUKEMIA - A PILOT-STUDY, British Journal of Haematology, 102(1), 1998, pp. 327-327

Authors: KASPERS GJL PIETERS R VANZANTWIJK CH VANWERING ER VANDERDOESVANDENBERG A VEERMAN AJP
Citation: Gjl. Kaspers et al., PREDNISOLONE RESISTANCE IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA - VITRO-VIVO CORRELATIONS AND CROSS-RESISTANCE TO OTHER DRUGS, Blood, 92(1), 1998, pp. 259-266

Authors: KASPERS GJL VEERMAN AJP PIETERS R VANZANTWIJK CH SMETS LA VANWERING ER DENBERG AV
Citation: Gjl. Kaspers et al., IN-VITRO CELLULAR-DRUG RESISTANCE AND PROGNOSIS IN NEWLY-DIAGNOSED CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA, Blood, 90(7), 1997, pp. 2723-2729

Authors: KASPERS GJL VEERMAN AJP VANWERING ER VANDERLINDENSCHREVER BEM VANZANTWIJK CH VANDERDOESVANDENBERG A PIETERS R
Citation: Gjl. Kaspers et al., PROGNOSTIC-SIGNIFICANCE OF PEANUT AGGLUTININ BINDING IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA, Leukemia, 10(4), 1996, pp. 675-681

Authors: KASPERS GJL VEERMAN AJP POPPSNIJDERS C LOMECKY M VANZANTWIJK CH SWINKELS LMJW VANWERING ER PIETERS R
Citation: Gjl. Kaspers et al., COMPARISON OF THE ANTILEUKEMIC ACTIVITY IN-VITRO OF DEXAMETHASONE ANDPREDNISOLONE IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA, Medical and pediatric oncology, 27(2), 1996, pp. 114-121

Authors: KASPERS GJL PIETERS R VANZANTWIJK CH VANWERING ER VEERMAN AJP
Citation: Gjl. Kaspers et al., CLINICAL AND CELL BIOLOGICAL FEATURES RELATED TO CELLULAR-DRUG RESISTANCE OF CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA CELLS, Leukemia & lymphoma, 19(5-6), 1995, pp. 407-416

Authors: KASPERS GJL SMETS LA PIETERS R VANZANTWIJK CH VANWERING ER VEERMAN AJP
Citation: Gjl. Kaspers et al., FAVORABLE PROGNOSIS OF HYPERDIPLOID COMMON ACUTE LYMPHOBLASTIC-LEUKEMIA MAY BE EXPLAINED BY SENSITIVITY TO ANTIMETABOLITES AND OTHER DRUGS - RESULTS OF AN IN-VITRO STUDY, Blood, 85(3), 1995, pp. 751-756

Authors: KASPERS GJL KARDOS C PIETERS R VANZANTWIJK CH KLUMPER E HAHLEN K DEWAAL FC VANWERING ER VEERMAN AJP
Citation: Gjl. Kaspers et al., DIFFERENT CELLULAR-DRUG RESISTANCE PROFILES IN CHILDHOOD LYMPHOBLASTIC AND NONLYMPHOBLASTIC LEUKEMIA - A PRELIMINARY-REPORT, Leukemia, 8(7), 1994, pp. 1224-1229

Authors: KASPERS GJL VEERMAN AJP PIETERS R BROEKEMA GJ HUISMANS DR KAZEMIER KM LOONEN AH ROTTIER MAA VANZANTWIJK CH HAHLEN K VANWERING ER
Citation: Gjl. Kaspers et al., MONONUCLEAR-CELLS CONTAMINATING ACUTE LYMPHOBLASTIC LEUKEMIC SAMPLES TESTED FOR CELLULAR-DRUG RESISTANCE USING THE METHYL-THIAZOL-TETRAZOLIUM ASSAY, British Journal of Cancer, 70(6), 1994, pp. 1047-1052

Authors: KASPERS GJL VEERMAN AJP VANWERING ER VANDERLINDENSCHREVER BEM VANZANTWIJK CH VANDERDOESVANDENBERG A PIETERS R
Citation: Gjl. Kaspers et al., PEANUT AGGLUTININ (PNA) BINDING AND ITS RELATION WITH IMMUNOPHENOTYPEAND DRUG-RESISTANCE IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL), Blood, 84(10), 1994, pp. 10000309-10000309

Authors: KASPERS GJL VEERMAN AJP PIETERS R VANZANTWIJK CH VANWERING ER VANDERDOESVANDENBERG A
Citation: Gjl. Kaspers et al., IN-VITRO DRUG-RESISTANCE PROFILE - STRONGEST PROGNOSTIC FACTOR IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL), Blood, 84(10), 1994, pp. 10000516-10000516
Risultati: 1-13 |